Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorAmer, Fatma
dc.contributor.authorYousif, Monkez M
dc.contributor.authorHammad, Noha M
dc.contributor.authorGarcia Cehic, Damir
dc.contributor.authorNieto Aponte, Leonardo
dc.contributor.authorRodríguez Frias, Francisco
dc.contributor.authorQuer Sivila, Josep
dc.contributor.authorRando Segura, Ariadna
dc.contributor.authorGregori Font, Josep
dc.contributor.authorEsteban Mur, Juan Ignacio
dc.date.accessioned2020-07-29T09:52:30Z
dc.date.available2020-07-29T09:52:30Z
dc.date.issued2019-09-10
dc.identifier.citationAmer F, Yousif MM, Hammad NM, Garcia-Cehic D, Gregori J, Rando-Segura A, et al. Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment. Infect Drug Resist. 2019 Sep 10;12:2799–807.
dc.identifier.issn1178-6973
dc.identifier.urihttps://hdl.handle.net/11351/5118
dc.descriptionSubstitucions associades a la resistència; RAS; Subtipus 4a
dc.description.sponsorshipThis study was supported by the Spanish Ministry of Health, Consumer Affairs, and Social Welfare, grant name: Plan Estrategico Nacional contra la Hepatitis C. This study was also funded by Instituto de Salud Carlos III, PI15/00856 and PI16/00337, cofinanced by CIBERehd (Consorcio Centro de Investigacion en Red de Enfermedades Hepaticas y Digestivas), which is funded by Instituto de Salud Carlos III and Centro para el Desarrollo Tecnologico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number, IDI-20151125
dc.language.isoeng
dc.publisherDovepress
dc.relation.ispartofseriesInfection and Drug Resistance;12
dc.rightsAttribution-NonCommercial 3.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/
dc.sourceScientia
dc.subjectHepatitis C - Tractament
dc.subjectÀcids nucleics - Anàlisi
dc.subjectResistència als medicaments
dc.subject.meshHepatitis C, Chronic
dc.subject.meshSequence Analysis, RNA
dc.subject.meshDrug Resistance, Multiple, Viral
dc.subject.mesh/drug therapy
dc.titleDeep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.2147/IDR.S214735
dc.subject.decshepatitis C crónica
dc.subject.decsanálisis de secuencias de ARN
dc.subject.decsfarmacorresistencia viral múltiple
dc.subject.decs/tratamiento farmacológico
dc.relation.publishversionhttps://www.dovepress.com/deep-sequencing-study-of-hcv-g4a-resistance-associated-substitutions-i-peer-reviewed-article-IDR
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Amer F, Hammad NM] Department of Medical Microbiology and Immunology, Faculty of Medicine, Medical College, Zagazig University, Zagazig, Egypt. [Yousif MM] Internal Medicine Department , Faculty of Medicine, Medical College, Zagazig University, Zagazig, Egypt. [Garcia-Cehic D, Esteban JI, Quer J] Unitat d’Hepatologia, Servei de Medicina Interna, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Laboratori sobre els virus de la Hepatitis, Grup de Recerca Malalties Hepàtiques, Vall d'Hebron Institut Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain. [Gregori J] Unitat d’Hepatologia, Servei de Medicina Interna, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Laboratori sobre els virus de la Hepatitis, Grup de Recerca Malalties Hepàtiques, Vall d'Hebron Institut Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain. Business Development Department, Roche Diagnostics SL, Sant Cugat del Vallès, Spain. [Rando-Segura A, Nieto-Aponte L] Unitat d’Hepatologia, Servei de Bioquímica i Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Rodriguez-Frias F] Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain. Unitat d’Hepatologia, Servei de Bioquímica i Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid31571936
dc.identifier.wos000485894000001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00856
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00337
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple